このエントリーをはてなブックマークに追加
ID 47896
file
Thumnail k7872_1.pdf 161 KB
Thumnail k7872_2.pdf 177 KB
Thumnail k7872_3.pdf 1.43 MB
title alternative
HAICとソラフェニブで治療した進行肝細胞癌の予後不良症例の予測に治療4週後の血清HMGB1濃度が有用である
creator
Masuda, Kazuhiko
language
eng
nii type
Thesis or Dissertation
HU type
Doctoral Theses
DCMI type
text
format
application/pdf
text version
ETD
rights
(c) The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
relation
Masuda, K., Ono, A., Aikata, H. et al. J Gastroenterol (2018) 53: 107.
relation url
grantid
甲第7872号
degreeGrantor
広島大学(Hiroshima University)
degreename Ja
博士(医学)
degreename En
Doctor of Philosophy in Medical Science
degreelevel
doctoral
date of granted
2019-03-23
department
Graduate School of Biomedical & Health Sciences